Maria Borentain

Maria Borentain, MD, currently serves as the VP and Head of Cardiovascular and Renal Clinical Development at Bayer, a position held since November 2022. Prior to this role, Maria Borentain was with Bristol Myers Squibb from January 2011, advancing through various leadership positions including Executive Director, Clinical Development Team Lead for Cardiovascular, and Sr. Director of Clinical Evaluations and Collaborations. Additional roles at Bristol Myers Squibb included Medical Director of Global Clinical Research and European Medical Director for Diabetes and Cardiovascular. Maria Borentain holds a Medical Doctor degree in Cardiology from the University of Paris.